Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a terminology transition.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedRemoval of the 403 error page fragment, including the HTML header and Home link, indicating that the error page artifacts were deleted and the page now presents standard site content.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now shows a 403 Forbidden error in place of the study record details, with a basic header/footer visible, indicating access restrictions to the resource.SummaryDifference17%

- Check63 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous revision v3.6.5, indicating a deployment update.SummaryDifference0.1%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.